Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 7:52 PM View:  | Arcutis Biotherapeutics, Inc. (ARQT) | 19-Nov-24 | Sale | 1,775 | $9.68 | $17,190.30 | (< 1%) 183.15K to 181.37K | |
| 19-Nov-24 7:52 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 18-Nov-24 | Grant | 4,875 | -- | -- | 3% 178.27K to 183.15K | |
| 05-Aug-24 4:37 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 02-Aug-24 | Sale (Planned) | 5,220 | $9.02 | $47,064.00 | (3%) 188.51K to 183.29K | |
| 29-May-24 7:38 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 28-May-24 | Sale | 1,775 | $9.01 | $15,988.10 | (< 1%) 190.28K to 188.51K | |
| 29-May-24 7:38 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 27-May-24 | Grant | 4,875 | -- | -- | 3% 185.41K to 190.28K | |
| 03-May-24 4:22 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 02-May-24 | Sale (Planned) | 5,016 | $8.74 | $43,828.80 | (3%) 190.42K to 185.41K | |
| 06-Mar-24 10:00 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 04-Mar-24 | Sale (Planned) | 3,760 | $11.12 | $41,815.70 | (2%) 194.18K to 190.42K | |
| 15-Feb-24 6:32 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 13-Feb-24 | Grant | 119,550 | -- | -- | 160% 74.63K to 194.18K | |
| 17-Jan-24 4:32 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 12-Jan-24 | Grant | 28,000 | -- | -- | 60% 46.63K to 74.63K | |
| 21-Nov-23 5:47 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 21-Nov-23 | Sale | 1,850 | $1.98 | $3,661.15 | (4%) 48.48K to 46.63K | |
| 21-Nov-23 5:47 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 18-Nov-23 | Grant | 4,875 | -- | -- | 11% 43.61K to 48.48K | |
| 02-Jun-23 8:31 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 31-May-23 | Grant | 1,463 | $6.38 | $9,333.94 | 3% 43.98K to 45.44K | |
| 02-Jun-23 8:31 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 31-May-23 | Sale | 1,830 | $7.80 | $14,278.20 | (4%) 45.44K to 43.61K | |
| 02-Jun-23 8:31 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 27-May-23 | Grant | 4,875 | -- | -- | 12% 39.1K to 43.98K | |
| 06-Mar-23 6:52 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 02-Mar-23 | Grant | 21,000 | -- | -- | 107% 19.54K to 40.53K | |
| 06-Mar-23 6:52 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 02-Mar-23 | Sale (Planned) | 1,434 | $15.83 | $22,695.80 | (4%) 40.53K to 39.1K | |
| 22-Nov-22 7:06 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 21-Nov-22 | Sale | 1,720 | $18.19 | $31,288.90 | (8%) 21.25K to 19.54K | |
| 22-Nov-22 7:06 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 18-Nov-22 | Grant | 4,875 | -- | -- | 30% 16.38K to 21.25K | |
| 02-Jun-22 4:48 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 02-Jun-22 | Sale | 1,795 | $19.73 | $35,418.60 | (10%) 18.18K to 16.38K | |
| 02-Jun-22 4:48 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 27-May-22 | Grant | 4,875 | -- | -- | 37% 13.3K to 18.18K | |
| 07-Mar-22 8:52 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 03-Mar-22 | Grant | 13,300 | -- | -- | 100% 0 to 13.3K | |
| 07-Sep-21 5:42 PM View: | Halozyme Therapeutics, Inc. (HALO) | 04-Sep-21 | Payment of Exercise | 3,412 | $42.22 | $144,055.00 | (15%) 23.46K to 20.05K | |
| 07-Sep-21 5:42 PM View: | Halozyme Therapeutics, Inc. (HALO) | 04-Sep-21 | Option Exercise | 6,883 | -- | -- | 42% 16.58K to 23.46K | |
| 12-Feb-21 7:10 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Feb-21 | Payment of Exercise | 2,047 | $49.84 | $102,022.00 | (11%) 18.63K to 16.58K | |
| 12-Feb-21 7:10 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Feb-21 | Option Exercise | 4,129 | -- | -- | 28% 14.5K to 18.63K | |
| 12-Feb-21 7:10 PM View: | Halozyme Therapeutics, Inc. (HALO) | 10-Feb-21 | Payment of Exercise | 3,203 | $50.60 | $162,072.00 | (18%) 17.7K to 14.5K | |
| 12-Feb-21 7:10 PM View: | Halozyme Therapeutics, Inc. (HALO) | 10-Feb-21 | Option Exercise | 6,257 | -- | -- | 55% 11.44K to 17.7K | |
| 04-Sep-20 6:13 PM View: | Halozyme Therapeutics, Inc. (HALO) | 04-Sep-20 | Payment of Exercise | 2,380 | $27.70 | $65,926.00 | (17%) 13.82K to 11.44K | |
| 04-Sep-20 6:13 PM View: | Halozyme Therapeutics, Inc. (HALO) | 04-Sep-20 | Option Exercise | 6,884 | -- | -- | 99% 6.94K to 13.82K | |
| 13-Feb-20 6:41 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Feb-20 | Payment of Exercise | 1,681 | $20.00 | $33,620.00 | (20%) 8.62K to 6.94K | |
| 13-Feb-20 6:41 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Feb-20 | Option Exercise | 4,130 | -- | -- | 92% 4.49K to 8.62K |